ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARK VOSLER DO

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 3001

$1.12M Total Retail Price of All Prescriptions

Rank: 81 out of 3001

538 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 538 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 16,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 793 708 1 6
LISINOPRIL 649 534 2 2
AMLODIPINE BESYLATE 635 560 3 5
SIMVASTATIN 632 541 4 1
OMEPRAZOLE 613 451 5 4
LEVOTHYROXINE SODIUM 595 472 6 3
HYDROCODONE-ACETAMINOPHEN 580 332 S3 7 7
METOPROLOL TARTRATE 462 375 8 8
WARFARIN SODIUM 439 405 9 12
POTASSIUM CHLORIDE 423 390 10 15
LANTUS 359 271 11 47
GABAPENTIN 349 287 12 14
DONEPEZIL HCL 332 322 13 27
METFORMIN HCL 328 223 14 9
GLYBURIDE 318 260 R 15 62
CITALOPRAM HBR 312 255 16 16
LOVASTATIN 210 179 17 38
RANITIDINE HCL 199 128 18 41
NAMENDA 191 186 19 40
TRAMADOL HCL 190 142 20 17
NOVOLOG 177 148 21 94
SERTRALINE HCL 175 149 22 20
MIRTAZAPINE 173 146 23 44
ALLOPURINOL 170 137 24 35
TAMSULOSIN HCL 161 134 25 29
CARVEDILOL 153 124 26 25
NEXIUM 152 89 27 23
IBUPROFEN 152 117 27 74
ROPINIROLE HCL 151 132 29 88
METOPROLOL SUCCINATE 150 139 30 19
AZITHROMYCIN 150 108 30 36
PRAVASTATIN SODIUM 147 140 32 13
ATENOLOL 146 126 33 18
CEPHALEXIN 145 131 34 86
CLOPIDOGREL 142 123 35 28
POLYETHYLENE GLYCOL 3350 138 91 36 55
FINASTERIDE 137 137 37 92
ALENDRONATE SODIUM 128 125 38 26
ATORVASTATIN CALCIUM 125 90 39 11
METHYLPREDNISOLONE 123 105 40 121
MELOXICAM 120 119 41 34
PAROXETINE HCL 118 70 42 60
NYSTOP 117 80 43 167
OXYCODONE-ACETAMINOPHEN 116 51 S2 44 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 74 45 22
GEMFIBROZIL 100 82 46 117
TRAZODONE HCL 98 80 47 37
GLIMEPIRIDE 97 70 48 31
RISPERIDONE 96 49 49 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 83 50 77
PLAVIX 92 74 51 46
PROAIR HFA 92 51 51 30
AMITRIPTYLINE HCL 92 54 R 51 85
FENOFIBRATE 90 63 54 59
TRIAMTERENE-HYDROCHLOROTHIAZID 88 67 55 203
HYDROCHLOROTHIAZIDE 86 65 56 10
ALPRAZOLAM 85 61 57 98
KLOR-CON M20 83 66 58 52
PROMETHAZINE HCL 82 53 R 59 93
FAMOTIDINE 80 80 60 68
DICYCLOMINE HCL 80 17 60 202
LOSARTAN POTASSIUM 79 61 62 21
TRIAMTERENE-HCTZ 78 72 63 48
BUSPIRONE HCL 78 65 63 91
ADVAIR DISKUS 76 51 65 58
ZOLPIDEM TARTRATE 75 44 66 24
FLUOXETINE HCL 74 27 67 61
NYSTATIN 74 61 67 149
PREDNISONE 73 64 69 39
CIPROFLOXACIN HCL 72 65 70 56
SPIRIVA 71 53 71 57
EXELON 69 68 72 108
HYDRALAZINE HCL 69 68 72 104
FLUTICASONE PROPIONATE 67 31 74 42
GLIPIZIDE ER 67 52 74 130
QUETIAPINE FUMARATE 65 65 76 66
PANTOPRAZOLE SODIUM 64 60 77 43
CYMBALTA 62 29 78 53
GLYBURIDE-METFORMIN HCL 62 32 R 78 196
KETOCONAZOLE 62 62 78 185
LEVOFLOXACIN 62 52 78 115
CYCLOBENZAPRINE HCL 62 0 R 78 73
FENTANYL 61 61 S2 83 76
PROPRANOLOL HCL 60 38 84 136
AMLODIPINE BESYLATE-BENAZEPRIL 59 56 85 78
CELEBREX 59 46 85 89
DIOVAN 59 47 85 50
SPIRONOLACTONE 58 46 88 75
GLIPIZIDE 58 44 88 67
LEVETIRACETAM 58 38 88 112
CLONIDINE HCL 58 46 88 64
METFORMIN HCL ER 57 57 92 51
NABUMETONE 55 32 93 191
SINGULAIR 55 26 93 95
METHOCARBAMOL 55 22 R 93 179
AMPICILLIN TRIHYDRATE 53 47 96 374
LANTUS SOLOSTAR 52 15 97 80
ENABLEX 52 28 97 237
RESTASIS 52 52 97 323
CEFTRIAXONE 52 52 97 209
JANUVIA 52 33 97 54
DOXYCYCLINE HYCLATE 51 46 102 105
PEN NEEDLE 50 18 103 128
TIZANIDINE HCL 50 33 103 101
LYRICA 50 26 103 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.